ArticleJournal of advanced research2024

Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.

Bo-Ram Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.